Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study
(Paediatric Rheumatology International Trials Organisation (PRINTO)) van Straalen, Joeri W.; de Roock, Sytze; Giancane, Gabriella; Consolaro, Alessandro; Rygg, Marite; Nordal, Ellen B.; Rubio-Pérez, Nadina; Jelušić, Marija; De Inocencio, Jaime; Vojinovic, Jelena; Wulffraat, Nico M.; Bruijning-Verhagen, Patricia C. J.; Ruperto, Nicolino; Swart, Joost F.
Cite this document
van Straalen, J. W., de Roock, S., Giancane, G., Consolaro, A., Rygg, M., Nordal, E. B. ... Swart, J. F. (2022). Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study. Pediatric Rheumatology, 20. (1). doi: 10.1186/s12969-022-00763-x
van Straalen, Joeri W., et al. "Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study." Pediatric Rheumatology, vol. 20, no. 1, 2022. https://doi.org/10.1186/s12969-022-00763-x
van Straalen, Joeri W., Sytze de Roock, Gabriella Giancane, Alessandro Consolaro, Marite Rygg, Ellen B. Nordal, Nadina Rubio Pérez, et al. "Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study." Pediatric Rheumatology 20, no. 1 (2022). https://doi.org/10.1186/s12969-022-00763-x
van Straalen, J. W., et al. (2022) 'Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study', Pediatric Rheumatology, 20(1). doi: 10.1186/s12969-022-00763-x
van Straalen JW, de Roock S, Giancane G, Consolaro A, Rygg M, Nordal EB, and sur.. Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study. Pediatric Rheumatology [Internet]. 2022 November 14 [cited 2024 August 20];20(1). doi: 10.1186/s12969-022-00763-x
J. W. van Straalen, et al., "Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study", Pediatric Rheumatology, vol. 20, no. 1, November 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:509097. [Accessed: 20 August 2024]